Growth Hormone Deficiency
📧 Sign up to get email alerts when something new happens for Growth Hormone Deficiency.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-21EMA Authorised: Ngenla (somatrogon) — Pfizer Europe MA EEIG
Ngenla (somatrogon) has been authorized by the EMA for growth and development indications in the European Union.
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) [Phase 2]
Phase 2 trial results for LUM-201 in children with growth hormone deficiency have been completed with results posted.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA
A US non-interventional study to evaluate the effectiveness and safety of SKYTROFA (somatrogon) in patients with growth hormone deficiency; …
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency [Phase 3]
This Clinical Trial Update indicates that a Phase 3 study of LUM-201 in children with Growth Hormone Deficiency is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD) [Phase 1]
A Phase 1 clinical trial evaluating GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD) is currently recruiting to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213) [Phase 2]
Phase 2 trial of LUM-201 in children with Growth Hormone Deficiency has completed and results have been posted.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®
Post-marketing surveillance study evaluating long-term use of Sogroya for adult growth hormone deficiency.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information
This is a long-term safety follow-up study of adults with growth hormone deficiency treated with Sogroya (somapacitan) to monitor safety ove…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD) [Phase 3]
A Phase 3 clinical trial assessing growth hormone replacement therapy in veterans with adult growth hormone deficiency and mild traumatic br…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters
An ongoing long-term safety follow-up study in paediatric participants with growth hormone deficiency treated with somapacitan to monitor sa…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Effects of GH and Lirglutide on AgRP [Phase 4]
A Phase 4 clinical trial update on the effects of Growth Hormone and Lirglutide on AgRP, enrolling healthy participants and individuals with…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of GenSci134 in Children With Growth Hormone Deficiency (PGHD) [Phase 1, Phase 2]
A clinical trial update for GenSci134 in children with growth hormone deficiency; the study is currently not recruiting.
-
FDA approval · 2026-02-27FDA Approved: SOGROYA — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for Sogroya (somapacitan) from Novo Nordisk, updating its labeling for use in growth hormone def…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD) [NA]
A clinical trial update for REMS25 evaluating REMS technology in diseases commonly associated with reduced bone mineral density; recruitment…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Evaluation of (Cardio)Metabolic and Auxological Outcomes of GHD Patients Under rhGH or LAGH With Stratification According to IGF-1 Levels [NA]
A clinical trial evaluating cardio-metabolic and growth outcomes in growth hormone deficiency patients treated with recombinant human growth…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin
A post-authorization safety study (PASS) is being conducted to monitor the safety of lonapegsomatropin in patients with growth hormone defic…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth Hormone
Pfizer-sponsored post-marketing surveillance in Korea evaluating Ngenla pre-filled pen for pediatric growth disturbance due to growth hormon…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Hypothalamic-Stratified Nursing Pathway for Pediatric Craniopharyngioma
A completed clinical trial from West China Hospital evaluated a hypothalamic-stratified nursing pathway for pediatric craniopharyngioma, inc…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone Deficiency [Phase 3]
Phase 3 trial update showing long-term efficacy and safety results for lonapegsomatropin in adults with growth hormone deficiency; the study…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India.
Pfizer is enrolling pediatric patients in India to study somatrogon for growth hormone deficiency.
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Chromosome 18 Clinical Research Center
A clinical trial at The University of Texas Health Science Center at San Antonio is currently recruiting and focuses on chromosome abnormali…
-
EMA approval · 2025-12-16EMA Authorised: Ngenla (somatrogon) — Pfizer Europe MA EEIG
The European Medicines Agency has authorised Ngenla (somatrogon) from Pfizer Europe MA EEIG for treatment of pediatric growth hormone defici…
-
CLINICAL_TRIALS trial_result · 2025-12-16Clinical Trial Update: Growth and Asymmetric diMethylArginine
A completed clinical trial update from University Hospital Lille evaluating growth and asymmetric dimethylarginine in children with growth h…
-
EMA approval · 2025-12-04EMA Authorised: Sogroya (somapacitan) — Novo Nordisk A/S
EMA authorised Sogroya (somapacitan) from Novo Nordisk A/S for growth hormone-related indications in the EU, including adults with growth ho…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: A Study (Phase 1b/2) of GS3-007a Oral Treatment in Children With Growth Hormone Deficiency (PGHD) [Phase 1, Phase 2]
A Phase 1b/2 trial of GS3-007a for pediatric growth hormone deficiency is planned, with the study currently not yet recruiting and sponsored…